Cargando…
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term COVID-19 symptoms expressed by a substantial proportion of patients is not well understood. We determined whether vaccination with the BNT162b2 mRNA vaccine was associated with incidence of reporting long-term sy...
Autores principales: | Kuodi, Paul, Gorelik, Yanay, Zayyad, Hiba, Wertheim, Ofir, Wiegler, Karine Beiruti, Abu Jabal, Kamal, Dror, Amiel A., Nazzal, Saleh, Glikman, Daniel, Edelstein, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411827/ https://www.ncbi.nlm.nih.gov/pubmed/36028498 http://dx.doi.org/10.1038/s41541-022-00526-5 |
Ejemplares similares
-
Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel
por: Kuodi, Paul, et al.
Publicado: (2023) -
Changes in Quality of Life Following SARS-CoV-2 Infection Among Jewish and Arab Populations in Israel: A Cross-Sectional Study
por: Elsinga, Jelte, et al.
Publicado: (2023) -
Associations between reported post-COVID-19 symptoms and subjective well-being, Israel, July 2021 – April 2022
por: Gorelik, Yanay, et al.
Publicado: (2023) -
Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021) -
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021)